SONDQ (SONDQ) Stock Price & Analysis
SONDQ (SONDQ) closed at USD 0 on Wednesday, October 14, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0; the Oct 14, 2026 session ranged USD 0–0.01 on volume of 192,726 shares. Market capitalization is —, with a 52-week range of USD 0–1.65 (PNK). Source: Nexqual, retrieved October 16, 2026 at 06:45 UTC.
Also available as compact Markdown for AI agents: nexqual.com/SONDQ.md
Key facts (SONDQ)
- Total return with dividends: 1Y -100.0% vs S&P 500 +18.1%; 5Y -100.0% vs S&P 500 +85.1%.
Total return (dividends reinvested) (SONDQ)
| 1Y (from 2025-10-16) | 5Y (from 2022-01-17) | |
|---|---|---|
| Total return | -100.0% | -100.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -100.0% | -95.1% |
| Volatility (annualized) | 848.5% | 357.5% |
| Max drawdown | -100.0% (Oct 2025→Jan 2026) | -100.0% (Jan 2022→Jan 2026) |
Key Statistics (as of October 16, 2026 at 06:45 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0.01 |
| 52-Week Range | USD 0 – 1.65 |
| Volume | 192,726 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (SONDQ)
Nexqual's technical model rates SONDQ "SELL" based on 1 bullish and 5 bearish signals across 126 daily candles, as of October 16, 2026 at 06:45 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.6 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
Financial Health Score (SONDQ)
Nexqual rates SONDQ's overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 06:45 UTC.
| Growth | Strong — Revenue +31% YoY (annual) |
|---|---|
| Profitability | Critical — Gross margin 11%, operating -0% |
| Balance Sheet | Mixed — $27M cash vs $1.25B debt |
| Cash Flow | Weak — Operating cash flow -$80M (TTM) |
| Efficiency | Mixed — No data |
Leadership (SONDQ)
SONDQ is led by Janice L. Sears (age 64), Chairman of the Board & Interim CEO, per Nexqual as of October 16, 2026 at 06:45 UTC.
| Chairman of the Board & Interim CEO | Janice L. Sears (age 64) |
|---|---|
| Director of Strategic Finance | Ellie Ducommun |
Major Backers & Investors (SONDQ)
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 0.34% |
Source: Nexqual, October 16, 2026 at 06:45 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BHILQ | Benson Hill, Inc. | USD 0 | ▲ 0% |
| ANGH | Anghami Inc. | USD 3.27 | ▼ 11.14% |
| BBLG | Bone Biologics Corp | USD 0.39 | ▼ 9.86% |
| VRAX | Virax Biolabs Group Limited | USD 1.62 | ▼ 6.79% |
| REVB | Revelation Biosciences, Inc. | USD 0.76 | ▲ 4.38% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 06:45 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt